About this trial
In a research project, investigators want to study the course of the disease of axial spondylitis: the causes of disease onset, prognosis, and treatment effects. The goal is to improve treatment and in the long run also prevention of the disease. The project has a focus on the body\'s own substance prostaglandin, and its proinflammatory role in spondylitis, but also other substances may be analyzed in blood and urine samples.
The purpose of the research project is include newly diagnosed treatment-naive patients with axial spondyloarthritis, to follow them after 1 and 2 years after treatment start, to collect clinical data, questionnaires, blood and urinsamples to find blood or urine markers that can be used for precision therapy of axial spondylitis.
Eligibility criteria
Qualifiers
newly diagnosed patients with axial spondyloarthritis
treatment-naive
18 years of age or older
Swedish-speaking
Disqualifiers
DMARD treatment,
ongoing infection
ongoing malignancy
Trial design
Treatments tested in this trial
- Not listed
Trial groups
Sponsors and collaborators
Karolinska Institutet
Lead sponsor
Karolinska University Hospital
Collaborator